Biopharmaceuticals: The Economic Equation

AUTOR(ES)
FONTE

BioCommunications LLC

RESUMO

Biotech continues to search for the right formula to give payers and investors higher returns. Finding common ground with insurers and regulators on such issues as cost-effectiveness evaluations and biosimilars is part of the equation.

Documentos Relacionados